Guidelines for sexually transmitted diseases.
These guidelines for treatment of sexually transmitted diseases (STD) were established after careful deliberation by a group of experts and staff of the Centers for Disease Control (CDC). Commentary received after dissemination of preliminary documents to a large group of physicians was also considered. Certain aspects of these guidelines represent the best judgment of experts. The guidelines should not be construed as rules, but rather as a source of guidance within the United States. This is particularly true for topics that are controversial or based on limited data.
D001005:Anus Neoplasms / Q000188:drug therapy; D002690:Chlamydia Infections / Q000188:drug therapy; D003218:Condylomata Acuminata / Q000188:drug therapy; D005260:Female; D005833:Genital Neoplasms, Female / Q000188:drug therapy; D006069:Gonorrhea / Q000188:drug therapy; D006558:Herpes Genitalis / Q000188:drug therapy; D006801:Humans; D007231:Infant, Newborn; D008297:Male; D009920:Orchitis / Q000188:drug therapy; D000292:Pelvic Inflammatory Disease / Q000188:drug therapy; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000188:drug therapy; D012749:Sexually Transmitted Diseases / Q000188:drug therapy*; D014247:Trichomonas Vaginitis / Q000188:drug therapy; D014522:Urethral Diseases / Q000188:drug therapy